Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.31 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 6/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27810339 | 1.00 | CYP3A4 (0.41) | CYP3A4TDP1ALDH1A1ALOX15ESR1 | |
| SCHEMBL289857 | 0.95 | CYP3A4 (0.45) | CYP3A4TDP1ALDH1A1ALOX15ESR1 | |
| Hydrochloric Acid SCHEMBL31568007 | 0.92 | CYP3A4 (0.43) | CYP3A4TDP1ALDH1A1ALOX15ESR1 | |
| SCHEMBL18796532 | 0.92 | CYP3A4 (0.43) | CYP3A4TDP1ALDH1A1ALOX15ESR1 | |
| SCHEMBL19093066 | 0.92 | CYP3A4 (0.43) | CYP3A4TDP1ALDH1A1ALOX15ESR1 | |
| Bromide SCHEMBL28700347 | 0.92 | CYP3A4 (0.43) | CYP3A4TDP1ALDH1A1ALOX15ESR1 | |
| Hydrochloric Acid SCHEMBL31467528 | 0.92 | CYP3A4 (0.43) | CYP3A4TDP1ALDH1A1ALOX15ESR1 | |
| SCHEMBL3645144 | 0.92 | CYP3A4 (0.43) | CYP3A4TDP1ALDH1A1ALOX15ESR1 | |
| SCHEMBL14696690 | 0.92 | CYP3A4 (0.43) | CYP3A4TDP1ALDH1A1ALOX15ESR1 | |
| SCHEMBL28001639 | 0.87 | CYP3A4 (0.39) | CYP3A4TDP1ALDH1A1ALOX15ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021114639-A1 | NEW-TYPE OXAZOLIDINONE COMPOUNDS AND PREPARATION METHOD THEREFOR | 华创合成制药股份有限公司 | 2021-06-17 | — | — | WO | disclosed |
| US-10392476-B2 | Polymers comprising amino dihydrophenanthrene repeating units and organic electronic devices using the same | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2019-08-27 | — | — | US | disclosed |
| EP-2949655-B1 | REACTION CATALYST FOR CROSS COUPLING AND METHOD FOR MANUFACTURING AROMATIC COMPOUND | HOKKO CHEM IND CO (JP) | 2019-05-15 | — | — | EP | disclosed |
| US-20180171076-A1 | POLYMER AND DEVICE | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2018-06-21 | — | — | US | disclosed |
| US-9707551-B2 | Reaction catalyst for cross-coupling and method for manufacturing aromatic compound | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2017-07-18 | — | — | US | disclosed |
| US-20150360214-A1 | REACTION CATALYST FOR CROSS-COUPLING AND METHOD FOR MANUFACTURING AROMATIC COMPOUND | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2015-12-17 | — | — | US | disclosed |
| EP-2949655-A1 | REACTION CATALYST FOR CROSS COUPLING AND METHOD FOR MANUFACTURING AROMATIC COMPOUND | Hokko Chemical Industry Co., Ltd. (JP) | 2015-12-02 | — | — | EP | disclosed |
| EP-2364976-B1 | S1P receptor modulating compounds and use thereof | EPIX PHARM INC (US) | 2014-10-08 | — | — | EP | disclosed |
| EP-2364976-A1 | S1P receptor modulating compounds and use thereof | EPIX Pharmaceuticals, Inc. (US) | 2011-09-14 | — | — | EP | disclosed |
| US-20110212940-A1 | S1P Receptor Modulating Compounds and Use Thereof | EPIX PHARMACEUTICALS, INC. (US) | 2011-09-01 | — | — | US | disclosed |
| US-20080027036-A1 | S1P receptor modulating compounds and use thereof | EPIX DELAWARE, INC. (US) | 2008-01-31 | — | — | US | disclosed |
| US-7312350-B2 | Process for preparing arylalkynes | LANXESS DEUTSCHLAND GMBH (DE) | 2007-12-25 | — | — | US | disclosed |
| WO-2007109334-A2 | SIP RECEPTOR MODULATING COMPOUNDS AND USE THEREOF | EPIX DELAWARE, INC. (US) | 2007-09-27 | — | — | WO | disclosed |
| US-7238722-B2 | process which start from easily obtainable reactants to form pyrazolylalkines, used as chemical intermediates for acaricides and insecticdes | LANXESS DEUTSCHLAND GMBH (DE) | 2007-07-03 | — | — | US | disclosed |
| US-7102046-B2 | By reaction of haloaromatics or arylsulfonates with olefins in presence of palladium catalyst, bulky nitrogen base and salt | BAYER AKTIENGESELLSCHAFT (DE) | 2006-09-05 | — | — | US | disclosed |
| US-6916839-B2 | Pyrazolylarylalkines | BAYER CHEMICALS AKTIENGESELLSCHAFT (DE) | 2005-07-12 | — | — | US | disclosed |
| US-20040229929-A1 | Pyrazolylalkines | LANXESS DEUTSCHLAND GMBH (DE) | 2004-11-18 | — | — | US | disclosed |
| US-20040192952-A1 | Process for preparing arylalkynes | LANXESS DEUTSCHLAND GMBH (DE) | 2004-09-30 | — | — | US | disclosed |
| US-20040142820-A1 | Pyrazolylarylalkines | VENTURE LENDING & LEASING IX, INC. | 2004-07-22 | — | — | US | disclosed |
| US-20030105353-A1 | Process for the arylation of olefins | LANXESS DEUTSCHLAND GMBH (DE) | 2003-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080027036-A1 | S1P receptor modulating compounds and use thereof | S1PR1, S1PR5, S1PR2 | SLC6A2 3530/4885ACHE 2843/4885CYP3A4 2766/4885 |
| US-20040229929-A1 | Pyrazolylalkines | CX3CR1, PROKR2, BDKRB2 | SLC6A2 4462/4885ACHE 999/4885CYP3A4 277/4885 |
| US-20030105353-A1 | Process for the arylation of olefins | NEK6, JUN, AOC2 | SLC6A2 162/4885ACHE 4596/4885CYP3A4 314/4885 |
| US-20110212940-A1 | S1P Receptor Modulating Compounds and Use Thereof | S1PR1, S1PR5, S1PR2 | SLC6A2 3530/4885ACHE 2843/4885CYP3A4 2766/4885 |
| US-20150360214-A1 | REACTION CATALYST FOR CROSS-COUPLING AND METHOD FOR MANUFACTURING AROMATIC COMPOUND | ALK, HRH4, HRH3 | SLC6A2 3809/4885ACHE 1033/4885CYP3A4 237/4885 |
| US-20040192952-A1 | Process for preparing arylalkynes | ARSA, STS, HDHD5 | SLC6A2 1093/4885ACHE 4109/4885CYP3A4 98/4885 |
| US-20040142820-A1 | Pyrazolylarylalkines | CBR3, PPOX, ALK | SLC6A2 4324/4885ACHE 905/4885CYP3A4 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.